{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:33:03Z","timestamp":1788957183549,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical features, neuroimaging characteristics, and prognosis of patients with anti\u2013leucine-rich glioma-inactivated 1 (LGI1) antibody associated encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 87 patients diagnosed with anti-LGI1 encephalitis during the acute phase, admitted to two tertiary hospitals in China between January 2022 and September 2024. Clinical data, neuroimaging findings, and follow-up outcomes were systematically analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary clinical manifestations included memory impairment, epileptic seizures, psychiatric and behavioral disturbances, sleep dysfunction, involuntary movements, faciobrachial dystonic seizures (FBDS), and autonomic dysfunction. Among 53 patients tested for thyroid function, 9 (17.0%) exhibited abnormalities. Hyponatremia was observed in 41 of 82 patients (50.0%), and hyperhomocysteinemia (HHCY) in 23 of 80 (28.7%). Among 68 patients who underwent cerebrospinal fluid (CSF) analysis, elevated intracranial pressure was observed in 10 (14.7%), pleocytosis in 22 (32.4%), and elevated protein levels in 27 (39.7%). Electrocardiographic abnormalities were identified in 26 of 42 patients (61.9%) without prior cardiovascular disease. MRI abnormalities were present in 75 of 80 patients (93.8%), most commonly affecting the temporal lobe (55.0%), hippocampus (51.2%), and amygdala (11.2%). PET imaging in 39 patients frequently revealed hypermetabolism in the basal ganglia and temporal lobe. All patients received first-line immunotherapy. Of the 63 patients with follow-up data, 59 (93.7%) achieved favorable outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-LGI1 encephalitis is an immune-mediated autoimmune disorder characterized by memory impairment, epileptic seizures, FBDS, psychiatric and behavioral disturbances, autonomic dysfunction, hyponatremia, and HHCY. Immunotherapy is generally effective, leading to favorable prognosis in the majority of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1703647","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:31:22Z","timestamp":1765780282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songke","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"577753","DOI":"10.1016\/j.jneuroim.2021.577753","article-title":"The changing spectrum of antibody-mediated encephalitis in China","volume":"361","author":"Ren","year":"2021","journal-title":"J Neuroimmunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.mcna.2024.09.001","article-title":"Autoimmune encephalitis","volume":"109","author":"Guasp","year":"2025","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1069368","DOI":"10.3389\/fimmu.2022.1069368","article-title":"The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined","volume":"13","author":"Mu\u00f1oz-S\u00e1nchez","year":"2022","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3760\/cma.j.cn113694-20220219-00118","article-title":"Chinese expert consensus on the diagnosis and management of autoimmune encephalitis (2022 edition)","volume":"9","author":"Wang","year":"2022","journal-title":"Chin J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"990553","DOI":"10.3389\/fneur.2022.990553","article-title":"Neurological disorders associated with glutamic acid decarboxylase 65 antibodies: clinical Spectrum and prognosis of a cohort from China","volume":"13","author":"Bai","year":"2022","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00018-021-04088-y","article-title":"The Lgi1 protein: molecular structure, physiological functions and disruption-related seizures","volume":"79","author":"Baudin","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/brain\/awy253","article-title":"LGI1 antibodies Alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17562864211073203","DOI":"10.1177\/17562864211073203","article-title":"Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1\/Caspr2 encephalitis: a prospective cohort study in Western China","volume":"15","author":"Guo","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","article-title":"Lgi1 antibody encephalitis: acute treatment comparisons and outcome","volume":"93","author":"Rodriguez","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1141","DOI":"10.1212\/wnl.0000000000012465","article-title":"Clinical course and features of seizures associated with LGI1-antibody encephalitis","volume":"97","author":"Smith","year":"2021","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"fcaf106","DOI":"10.1093\/braincomms\/fcaf106","article-title":"Modulating limbic circuits in temporal lobe epilepsy: impacts on seizures, memory, mood and sleep","volume":"7","author":"Kremen","year":"2025","journal-title":"Brain Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e200228","DOI":"10.1212\/nxi.0000000000200228","article-title":"Predictors and clinical characteristics of relapses in LGI1-antibody encephalitis","volume":"11","author":"Campetella","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/ndt.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2017.08.011","article-title":"Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis","volume":"77","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e14420","DOI":"10.1111\/cns.14420","article-title":"Homocysteine and Parkinson's disease","volume":"30","author":"Zhou","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1176\/appi.neuropsych.20120303","article-title":"Clinical features, immunotherapy, and outcomes of anti-leucine-rich glioma-Inactivated-1 encephalitis","volume":"34","author":"Huang","year":"2022","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e200155","DOI":"10.1212\/nxi.0000000000200155","article-title":"Electrolyte imbalance in anti-Lgi1 encephalitis: it is not all in your head","volume":"10","author":"Gadoth","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/biomedicines13030726","article-title":"Hashimoto's encephalopathy: clinical features, therapeutic strategies, and rehabilitation approaches","volume":"13","author":"Manocchio","year":"2025","journal-title":"Biomedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"821746","DOI":"10.3389\/fimmu.2022.821746","article-title":"Thyroid function and low free triiodothyronine in Chinese patients with autoimmune encephalitis","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.seizure.2019.01.013","article-title":"Sudden cardiac death in a patient with LGI1 antibody-associated encephalitis","volume":"65","author":"Rizzi","year":"2019","journal-title":"Seizure"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e64472","DOI":"10.7759\/cureus.64472","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis and life-threatening sinus node dysfunction: a case report, literature review, and analysis of 23 cases","volume":"16","author":"Khachatryan","year":"2024","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1086","DOI":"10.1212\/nxi.0000000000001086","article-title":"CSF findings in acute NMDAR and LGI1 antibody-associated autoimmune encephalitis","volume":"8","author":"D\u00fcrr","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2024.0126","article-title":"Magnetic resonance imaging characteristics of LGI1-antibody and Caspr2-antibody encephalitis","volume":"81","author":"Kelly","year":"2024","journal-title":"JAMA Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"949240","DOI":"10.3389\/fneur.2022.949240","article-title":"Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: a case report","volume":"13","author":"Cornacchini","year":"2022","journal-title":"Front Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"674368","DOI":"10.3389\/fneur.2021.674368","article-title":"Clinical characteristics and long-term prognosis of anti-LGI1 encephalitis: a single-center cohort study in Beijing, China","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1097\/rlu.0000000000004862","article-title":"Diagnostic superiority of 18 F-FDG pet over MRI in detecting anti-LGI1 autoimmune encephalitis: a comparative study with insights into Faciobrachial dystonic seizures mechanisms and recurrence identification","volume":"48","author":"Liang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"791014","DOI":"10.3389\/fneur.2021.791014","article-title":"Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: a systematic review","volume":"12","author":"Teng","year":"2021","journal-title":"Front Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/wnl.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1703647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:31:23Z","timestamp":1765780283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1703647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":28,"alternative-id":["10.3389\/fneur.2025.1703647"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1703647","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1703647"}}